HEB - Hemispherx Biopharma misses by $0.02 May, 16 2019 08:39 AM Hemispherx BioPharma Inc. Hemispherx Biopharma (NYSEMKT:HEB): Q1 GAAP EPS of -$0.07 misses by $0.02.Cash, cash equivalents and marketable securities of $4.9MPress ReleaseMore news on: Hemispherx Biopharma, Inc., Earnings news and commentary, Healthcare stocks news, ,